In triple-negative breast cancer (TNBC), TMAO improves ICI response via PERK-dependent pyroptosis: gasdermin E knockout blocks pyroptosis and anti-PD-1 synergism; PERK inhibition reverses CD8+ T cell activation (85, 177). Here, EIF2AK3 is linked to triple-negative breast carcinoma.